Literature DB >> 2687652

Disseminated herpes simplex virus infection in an apparently immunocompetent woman.

P C McMinn1, I S Lim, P E McKenzie, A G van Deth, A Simmons.   

Abstract

A young, previously healthy woman developed bilateral exudative tonsillitis that was associated with severe systemic symptoms. This was followed by evidence of multisystem disease with acute abdominal pain, raised liver enzyme levels, respiratory difficulty, increasing drowsiness and multiple vesicular skin lesions. Herpes simplex virus type-1 was isolated from skin lesions and a throat swab and herpes simplex virus type-1 antigen was detected in a liver biopsy sample. She recovered rapidly without any sequelae after treatment with intravenously administered acyclovir.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687652     DOI: 10.5694/j.1326-5377.1989.tb101292.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

Review 1.  Herpes latency, meningitis, radiculomyelopathy and disseminated infection.

Authors:  J J Sasadeusz; S L Sacks
Journal:  Genitourin Med       Date:  1994-12

2.  Mechanisms of herpes simplex virus type 1 reactivation.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells.

Authors:  M A Hardwicke; P A Schaffer
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman.

Authors:  Todd Czartoski; Charlie Liu; David M Koelle; Stephen Schmechel; Andrea Kalus; Anna Wald
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Fatal fulminant herpes simplex hepatitis following surgery in an adult.

Authors:  Yoshihiro Yokoi; Takeshi Kaneko; Tomoki Sawayanagi; Yasuo Takano; Yoichi Watahiki
Journal:  World J Clin Cases       Date:  2018-02-16       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.